Victoria Marie Knepp

Title: Victoria Marie Knepp: Innovator in Stable Protein and Nucleic Acid Formulations

Introduction

Victoria Marie Knepp is a notable inventor based in Ridgefield, CT (US). She has made significant contributions to the field of biochemistry through her innovative work on stable protein and nucleic acid formulations. Her research focuses on creating formulations that can withstand various conditions while maintaining their efficacy.

Latest Patents

Victoria holds a patent for her invention titled "Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity." This invention relates to stable non-aqueous formulations that are suspensions of proteinaceous substances or nucleic acids. The formulations are designed to remain in stable, dry powder form while being flowable, allowing for various delivery methods such as injection, transdermal administration, or oral delivery. These formulations can be stored at elevated temperatures for extended periods, making them particularly useful for long-term drug delivery.

Career Highlights

Victoria is associated with Alza Corporation, where she has contributed her expertise in developing innovative pharmaceutical formulations. Her work has been instrumental in advancing the field of drug delivery systems.

Collaborations

Throughout her career, Victoria has collaborated with esteemed colleagues, including Steven J Prestrelski and Jessica G Smith. These collaborations have further enhanced her research and development efforts in the pharmaceutical industry.

Conclusion

Victoria Marie Knepp's contributions to stable protein and nucleic acid formulations highlight her innovative spirit and dedication to advancing pharmaceutical science. Her work continues to impact the field positively, paving the way for more effective drug delivery solutions.